77 related articles for article (PubMed ID: 1702402)
1. [Effects of granulocyte colony-stimulating factor on peripheral white blood cell and platelet counts in mice pretreated with anticancer drugs].
Mizushima Y; Morikage T; Konishi K; Yano S
Hokkaido Igaku Zasshi; 1990 Nov; 65(6):628-31. PubMed ID: 1702402
[TBL] [Abstract][Full Text] [Related]
2. Effects of granulocyte colony-stimulating factor on hematopoietic injury induced by anticancer drugs in mice.
Mizushima Y; Morikage T; Kuwahara T; Yano S
J Biol Response Mod; 1990 Dec; 9(6):576-83. PubMed ID: 1705961
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
4. Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
Bernstein SH; Fay JP; Christiansen NP; Pinero L; Shah D; Stephan M; Herzig GP
Clin Cancer Res; 1997 Sep; 3(9):1519-26. PubMed ID: 9815838
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytopenia in association with splenomegaly during granulocyte-colony-stimulating factor treatment in mice is not caused by hypersplenism and is resolved spontaneously.
Takamatsu Y; Jimi S; Sato T; Hara S; Suzumiya J; Tamura K
Transfusion; 2007 Jan; 47(1):41-9. PubMed ID: 17207228
[TBL] [Abstract][Full Text] [Related]
6. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
Tanikawa S; Nakao I; Tsuneoka K; Nara N
Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
[TBL] [Abstract][Full Text] [Related]
8. [Feasibility of a cyclophosphamide methotrexate and 5-fluorouracil regime intravenously administered with and without granulocyte-colony stimulating factor in surgically treated breast carcinoma].
Garrone O; Del Mastro L; Mariani GL; Ardizzoni A; Venturini M; Rosso R
Minerva Med; 1993 Sep; 84(9):467-72. PubMed ID: 7504219
[TBL] [Abstract][Full Text] [Related]
9. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
Patchen ML; Fischer R; MacVittie TJ
Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
[TBL] [Abstract][Full Text] [Related]
10. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
Cairo MS; Plunkett JM; Schendel P; van de Ven C
Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.
Bronchud M; Scarffe JH; Thatcher N; Crowther D; Souza LM; Alton NK; Testa NG; Dexter TM
Behring Inst Mitt; 1988 Aug; (83):327-9. PubMed ID: 2467655
[TBL] [Abstract][Full Text] [Related]
12. [Middle-high dose of cyclophosphamide or conventional routine chemotherapy with increased dose of cyclophosphamide combined with G-CSF for mobilizing peripheral blood progenitor cells in patients with tumor].
Lu DP; Liu KY; Guo NL; Shi YK; He XH; Lou FD; Da WM; Zhang BL; Wang LX; Ke XY
Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):68-70. PubMed ID: 12697098
[TBL] [Abstract][Full Text] [Related]
13. MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
Riccardi A; Gobbi P; Danova M; Giordano M; Pieresca C; Bertoloni D; Brugnatelli S; Ascari E
Haematologica; 1993; 78(1):44-8. PubMed ID: 7684012
[TBL] [Abstract][Full Text] [Related]
14. Importance of timing of radioimmunotherapy after granulocyte colony-stimulating factor administration for peripheral blood stem cell harvest.
Juweid ME; Blumenthal RD; Lew W; Hajjar G; Rubin AD; Goldenberg DM
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3337s-3342s. PubMed ID: 10541383
[TBL] [Abstract][Full Text] [Related]
15. Studies on the efficacy of mast cell growth factor (c-kit ligand) in vitro as well as in vivo.
Hintz-Obertreis P; Weinmann E; Seiler FR
Behring Inst Mitt; 1991 Dec; (90):14-22. PubMed ID: 1724901
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
17. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.
Stroncek DF; Clay ME; Smith J; Ilstrup S; Oldham F; McCullough J
Transfusion; 1996 Jul; 36(7):596-600. PubMed ID: 8701454
[TBL] [Abstract][Full Text] [Related]
18. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.
Kushner BH; Heller G; Kramer K; Cheung NK
Cancer; 2000 Nov; 89(10):2122-30. PubMed ID: 11066054
[TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]